0000875320-24-000041.txt : 20240213
0000875320-24-000041.hdr.sgml : 20240213
20240213164851
ACCESSION NUMBER: 0000875320-24-000041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240209
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ambrose Kristen
CENTRAL INDEX KEY: 0001856587
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 24626960
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
wk-form4_1707860917.xml
FORM 4
X0508
4
2024-02-09
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001856587
Ambrose Kristen
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Chief Accounting Officer
1
Common Stock
2024-02-09
4
F
0
591
422.74
D
11050
D
Common Stock
2024-02-12
4
S
0
1374
420.24
D
9676
D
Transaction made pursuant to Ms.Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.
/s/ Christiana Stevenson, Attorney-in-Fact
2024-02-13